The global MRI systems market is valued at USD 7.0 billion in 2026 and is forecast to reach USD 9.65 billion by 2031, expanding at a compound annual growth rate of 6.6 percent. This expansion reflects structural shifts rather than cyclical fluctuations, rooted primarily in rising prevalence of chronic neurodegenerative and musculoskeletal disorders alongside demographic aging. The expanding elderly population, projected to reach nearly 80 million by 2050, will fuel demand for non-invasive, radiation-free diagnostic imaging capable of detecting Alzheimer’s disease, Parkinson’s disease, spinal degeneration, and joint pathology requiring frequent monitoring.
What is driving growth
Musculoskeletal disorders and neurological conditions are proliferating globally, driven by sedentary lifestyles and aging demographics. The projected geriatric population reaching nearly 80 million by 2050 will sharply increase demand for diagnosis and monitoring of Alzheimer’s disease, Parkinson’s disease, spine degeneration, and osteoarthritis. MRI remains the diagnostic standard for soft tissue and nervous system imaging, making it essential for detecting multiple sclerosis, spinal injuries, and chronic pain syndromes. Per-patient scan volume is rising as clinicians require frequent non-invasive imaging for treatment guidance and disease progression monitoring. Technological advancements including 3T and 7T high-field systems, functional MRI, diffusion tensor imaging, and hybrid imaging platforms are expanding clinical capability and accelerating adoption by improving diagnostic accuracy and reducing scan times.
Restraints and challenges
Helium supply constraints represent the most acute supply-side pressure, with hospitals consuming approximately 32% of global helium and Qatar controlling the majority of production capacity. A 2024 shortage, compounded by scheduled maintenance downtime and Ukraine conflict disruptions, triggered sharp price increases documented through April 2026. Conflict-related availability reductions have elevated MRI system operating costs and extended maintenance timelines. Input cost volatility and logistical disruptions continue compressing producer margins, particularly for regional manufacturers. Tightening environmental and safety standards across major markets are lengthening product development cycles and regulatory approval timelines.
Approximately 60% of Americans aged 65 and older live with multiple concurrent chronic conditions, each generating recurring demand for diagnostic imaging. By field strength, high and very-high field systems (3T and 7T) dominate clinical deployment, capturing 93.9% of the market in 2025. Fixed stationary systems represent the largest architectural segment, accounting for the majority of installations across hospital networks and diagnostic imaging centers.
Closed MRI systems command 79.7% of the 2025 market share, reflecting superior image quality and widespread adoption for brain, neurological, spine, and musculoskeletal applications. Brain and neurological imaging drives the highest growth rate among applications, supported by rising MS prevalence and stroke incidence globally. Regionally, Asia Pacific is positioned as the fastest-expanding market, projected to achieve a 7.4% CAGR through 2031, fueled by industrialization, rising per capita incomes, and expanding healthcare infrastructure across Southeast Asia and emerging economies.
Companies profiled
- Siemens Healthineers
- GE Healthcare
- Koninklijke Philips N.V
- FUJIFILM Corporation
- Canon Inc
- Neusoft Medical Systems Co. Ltd
- SternMed GmbH
- Hyperfine Inc
For complete market sizing, forecasts, and competitive intelligence, read the full MRI Systems Market — covering growth drivers, regional analysis, and leading company profiles through 2033.